Senseonics Holdings and Beta Bionics have paired up to develop an autonomous bionic pancreas that uses real-time data from Senseonics’ implantable Eversense continuous glucose monitoring system.

The partners plan to integrate the glucose data into the iLet Bionic Pancreas system, a dual-chamber autonomous infusion pump that mimics a biological pancreas.

Senseonics President and CEO Tim Goodnow said the combined technologies could create “a unique option” for diabetes management.